<DOC>
	<DOCNO>NCT00451542</DOCNO>
	<brief_summary>This study retrospective chart review patient treat bipolar disorder TVAMC past four year cross-referenced electronic pharmacy file receive prescription divalproex lamotrigine .</brief_summary>
	<brief_title>Divalproex vs. Lamotrigine Bipolar Disorder</brief_title>
	<detailed_description>The primary objective study assess long-term outcome bipolar patient treat divalproex versus lamotrigine retrospective chart review veteran measure time relapse significant mood episode ( i.e . mania depression ) . The primary hypothesis bipolar patient demonstrate significantly great time relapse treat divalproex compare treated lamotrigine . The secondary objective study assess safety relative tolerability divalproex lamotrigine population base discontinuation due side adverse effect .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Diagnosis Bipolar I Bipolar II disorder Prescription divalproex ( formulation except Depakene/valproic acid ) lamotrigine electronic pharmacy profile . Age 19 old Demonstrated stability least 4 week adequate dose medication ( least 50mg/d lamotrigine 15mg/kg/day divalproex ) . Treatment TVAMC least 6 month follow prescription divalproex lamotrigine . Primary diagnosis schizoaffective schizophrenia evaluation period . Prescription divalproex lamotrigine give concurrently observation period . History Dementia cognitive disorder</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Relapse</keyword>
	<keyword>Retrospective</keyword>
</DOC>